What's in Leadiant Biosciences, Inc.'s pipeline?

Leadiant Biosciences, Inc. has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Leadiant Biosciences, Inc.'s portfolio?

Top competitors by shared drug class: Avidity Biosciences, Inc., European Organisation for Research and Treatment of Cancer - EORTC, Ionis Pharmaceuticals, Inc., Isarna Therapeutics GmbH, NYU Langone Health.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/leadiant-biosciences-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Leadiant Biosciences, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Leadiant Biosciences, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Adagen	Adagen	phase 3			Other
EZN-2279	EZN-2279	phase 3	Antisense oligonucleotide	APOC3 mRNA	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Avidity Biosciences, Inc. · 1 shared drug class
European Organisation for Research and Treatment of Cancer - EORTC · 1 shared drug class
Ionis Pharmaceuticals, Inc. · 1 shared drug class
Isarna Therapeutics GmbH · 1 shared drug class
NYU Langone Health · 1 shared drug class
Sarepta Therapeutics, Inc. · 1 shared drug class
Ultragenyx Pharmaceutical Inc · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Leadiant Biosciences, Inc.:

Cite this brief

Drug Landscape (2026). Leadiant Biosciences, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/leadiant-biosciences-inc. Accessed 2026-06-10.